Found 0 matching trials
Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer N/A This is a feasibility study evaluating the use of a mathematical model to p...
Show More Location
University of New Mexico Comprehensive Cancer Center
Learn More & Join Trial
Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1) PHASE1 GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction PHASE2 This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Show More Location
The fourth hospital of Hebei Medical University
Learn More & Join Trial
EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients PHASE3 This phase 3 trial compares the addition of nivolumab to chemotherapy (carb...
Show More Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Learn More & Join Trial
A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC PHASE2 This is a prospective, multi-center, single arm study assessing the efficac...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer PHASE3 RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamid...
Show More Status
Active Not Recruiting
Location
Regional Medical Center
Learn More & Join Trial
A Controlled Clinical Trial Assessing the Efficacy of Vitamin B Prophylaxis in Attenuating Paclitaxel-induced Neuropathy and the Imperative Use of Gabapentin in Diabetic Ovarian Cancer Patients and the Potential Effect on Disease Response. NA The goal of this clinical trial is to learn if vitamin B prophylaxis is eff...
Show More Location
National Cancer Institute
Learn More & Join Trial
First-line Therapy in Metastatic PDAC PHASE2 The overarching hypothesis of this trial is that the NAPOLI regimen and alt...
Show More Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Learn More & Join Trial
A Pilot Study of PPX in Women With Metastatic Colorectal Cancer PHASE1 This study uses the drug PPX (also called Xyotax and CT-2103) in women with...
Show More Location
University of Southern California (U.S.C.)/ Norris Comprehensive Cancer Center
Learn More & Join Trial
Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy PHASE1 Quisinostat besides its own efficacy, which can potentially lead to better ...
Show More Location
Russian Oncological Research Center n.a. N. N. Blokhin RAMS
Learn More & Join Trial